Increased Anterior Cingulate Cortical Activity in Response to Fearful Faces: A Neurophysiological Biomarker that Predicts Rapid Antidepressant Response to Ketamine
Giacomo Salvadore(National Institutes of Health), Husseini K. Manji(National Institutes of Health), Christian Grillon(National Institutes of Health), Carlos A. Zarate(National Institute of Mental Health), Brian R. Cornwell(National Institutes of Health), Veronica Colon-Rosario(National Institutes of Health), Richard Coppola(United States Department of Health and Human Services)
Cited by 280
Related Papers
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
|Neuropsychopharmacology|2009|1.5k
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
|American Journal of Psychiatry|2019|888
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
|JAMA Psychiatry|2019|780
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754